Cardiovascular disease (CVD) is the leading cause of death in patients with diabetes mellitus. Several hypoglycemic agents have undergone CV outcome trials (CVOTs) that focus on patients with pre-existing CVD or are at high risk of developing CVD. In this issue of Diabetes News Nucleus, let us learn more about the anti-diabetic drugs and CV outcomes.
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details